LONDON and NEW YORK—Okyo Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, has announced the expansion of their scientific advisory board with the appointment of Marta Sacchetti, MD, PhD, an associate professor of ophthalmology at Link University in Rome, Italy. This appointment further enhances the company’s global scientific network with premier European specialists, Okyo Pharma said in the announcement.